Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q1- Text added to 2022 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
Aetna, affiliated, Alameda, Ashworth, Attorney, baseline, biosimilar, canceled, cap, capped, cessation, Comptroller, conflict, contesting, deepen, departure, Deposit, discarded, draft, driver, EEA, endpoint, faster, freely, gamma, gap, GP, harder, HIPAA, House, Hydroxybutyrate, IND, intervene, leave, lifted, Limb, MAA, MAPK, MAS, midterm, military, Monocarboxylate, Muscle, oncogenic, opposed, oromucosal, penalize, percent, Pharm, PhRMA, Portability, precondition, President, protein, redesign, reimposed, Restated, revealed, Russia, Scale, screening, smallest, spend, spent, spray, subpoena, successor, Tovey, UCB, Ukraine, Vice, withheld
Removed:
arise, customary, devote, Italian, rata, reclassified, remotely, Undisclosed
Valuein 2022 Q1 filing- Value in 2022 Q2 filing
Original filings
Filing view